InVivo Therapeutics
-
Financial
InVivo Therapeutics Announces Pricing of $13.2 Million Underwritten Public Offering
June 21, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the pricing of an underwritten public offering of 388,403…
Read More » -
Financial
InVivo Therapeutics Reports 2018 First Quarter Financial Results
May 07, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today provided a business and clinical update and reported financial results…
Read More » -
Financial
InVivo Therapeutics Provides Business Update
April 09, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq:NVIV) today provided a general business update. The company is announcing a…
Read More » -
Hospitals
InVivo Therapeutics Receives FDA Approval for Pivotal, Randomized, Controlled Trial of the Neuro-Spinal Scaffold™ in Patients with Acute Spinal Cord Injury
March 08, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the company has received supplemental Investigational Device Exemption…
Read More » -
Biologics
InVivo Therapeutics Announces Appointment of Richard Toselli, M.D., as President and Chief Executive Officer
February 05, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Richard Toselli, M.D., has been appointed President and…
Read More » -
Financial
InVivo Therapeutics Announces Purchase Agreement for up to $15 Million with Lincoln Park Capital
January 26, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that it has entered into a common stock…
Read More » -
Biologics
InVivo Therapeutics Announces Executive Management and Board Changes
December 18, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Richard Toselli, M.D., has been appointed Acting Chief…
Read More » -
Financial
InVivo Therapeutics Provides Business Update and Reports 2017 Third Quarter Financial Results
October 30, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today provided a general business update and reported financial results for…
Read More » -
Financial
InVivo Therapeutics Announces Publication in Neurosurgery of Lifetime Hospitalization Costs for Thoracic Spinal Cord Injury Patients by Severity Grade
September 05, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the publication of an article titled “Relationship of American…
Read More » -
Financial
InVivo Therapeutics Announces Exchange of Certain Warrants for Common Stock
August 10, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that it had exchanged certain outstanding warrants that were…
Read More » -
Financial
InVivo Therapeutics Provides Business Update and Reports 2017 Second Quarter Financial Results
August 08, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today provided a general business update and reported financial results for…
Read More » -
Biologics
InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer
July 10, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Richard Toselli, M.D., as Chief Medical…
Read More » -
Financial
InVivo Therapeutics Provides Clinical Update and Reports 2017 First Quarter Financial Results
May 04, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today provided a clinical update, an update on patients in…
Read More » -
Neuro
InVivo Therapeutics Announces Oral Presentations at the 2017 American Spinal Injury Association Annual Scientific Meeting
April 20, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the company will be giving two oral presentations…
Read More » -
Financial
InVivo Therapeutics Reports 2016 Year-end Financial Results and Business Update
March 10, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the year ended December 31,…
Read More »